We need to understand complexity to have better therapeutic options in future

On Tuesday, a one day symposium on Stem Cells and Cancer in the Indian context was held by Sathgen Biotech, National Centre for Cell Sciences and Somaiya Vidyavihar . The symposium brought together renowned personalities in the field of cancer research including Dr Michael Clarke, academicians, research students and industry delegates. There is a need for advancing research in the area of Cancer. Collaborations and discussions like these will bring in fresh new thinking and innovation. The conference was organised at Somaiya Vidyavihar to enlighten students of Medicaland Science College and other colleges about stem cells and cancer, pooling together the recent advances from the scientists and industry. “Since its inception in 2007, Sathgen Biotech has been working on developing drugs, which could work to eliminate cancer stem cell population, drugs which will also work in combination with existing chemotherapies to eliminate cancer-related mortality. Stem cell therapy is a new targeted method being evaluated by various academic and research groups across the globe. This symposium is being organised to address the most updated research and information available in the area of cancer stem cell therapy,” said Samir Somaiya, Director, Godavari Biorefineries of which Sathgen Biotech is a division. Dr Michael Clarke, Associate Director of Stanford Institute for Stem Cell and Regenerative Medicine and a pioneer in stem cell therapy of cancer said, “New paradigms from analytical tools to a deeper understanding of risk factors; from biomarkers to drug resistance and tumour recurrence are some of the many perspectives that have to be studied. Increase in cancer worldwide and the younger age at which it is occurring needs a clarion call for to come together and find solutions.” Dr Vijay Joshi, Principal, K J Somaiya College of Science and Commerce said, “In a cancer tumour even after radiation and chemotherapy, a very small fraction of the cell remains alive and cause recurrence of cancer. We need to understand complexity to have better therapeutic options in future.” Komal Padhariya, PhD Scholar, from NMIMS Mumbai, who attended the symposium said “I am delighted to be present at the symposium on stem cells and cancer. The conference enlightened many interesting topics in the field of stem cells and cancer for students to work in the future. I’m glad that I was a part of the conference and got to learn so much.”